期刊文献+

上皮-间质转化在结直肠癌中的研究进展 被引量:3

Advances in Research on Epithelial-mesenchymal Transition in Colorectal Cancer
下载PDF
导出
摘要 结直肠癌是常见的恶性肿瘤,侵袭转移是导致患者死亡的主要原因。上皮-间质转化(EMT)是上皮细胞转变为间质表型的过程,参与包括结直肠癌在内多种肿瘤的发生、发展、侵袭和转移,并与肿瘤化疗耐药密切相关。EMT的发生涉及多条信号通路,但其机制尚未完全阐明。本文就EMT机制及其在结直肠癌中的研究进展作一综述。 Colorectal cancer is a common malignant tumor,and invasion and metastasis are the major causes of death. Epithelial-mesenchymal transition( EMT) occurs along with transition from epithelial phenotype to mesenchymal phenotype. EMT is involved in the genesis,development,invasion and metastasis of various tumors including colorectal cancer. EMT is closely associated with chemotherapy resistance of tumors. Various signaling pathways are involved in the pathogenesis of EMT and its mechanism is not fully clear. This article reviewed the molecular mechanism and role of EMT in colorectal cancer.
出处 《胃肠病学》 2016年第5期307-310,共4页 Chinese Journal of Gastroenterology
关键词 上皮-间质转化 结直肠肿瘤 分子机制 信号通路 抗药性 肿瘤 Epithelial-Mesenchymal Transition Colorectal Neoplasms Molecular Mechanism Signal Pathway Drug Resistance Neoplasm
  • 相关文献

参考文献36

  • 1吴萍,冶亚平,丁彦青,廖雯婷.miR-30b对结直肠癌细胞转移潜能的影响[J].中国肿瘤临床,2014,41(11):679-683. 被引量:3
  • 2Yong-Bin Zheng,Hai-Ping Luo,Qiang Shi,Zhi-Nan Hao,Yu Ding,Qiu-Shuang Wang,Sheng-Bo Li,Gao-Chun Xiao,Shi-Lun Tong.miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2[J].World Journal of Gastroenterology,2014,20(21):6515-6522. 被引量:14
  • 3刘宝玉,黄杰安,刘诗权,李素艳,徐春燕,梁梦紫,谭林,覃蒙斌.NF-κB对人结肠癌细胞上皮间质转化及侵袭转移的影响[J].世界华人消化杂志,2014,22(23):3403-3409. 被引量:12
  • 4SK Halder,G Rachakonda,NG Deane,PK Datta.Smad7 induces hepatic metastasis in colorectal cancer. British Journal of Cancer . 2008
  • 5Ke Lei,Lu Ye,Yang Yang.RNA Interference-Mediated Silencing of Focal Adhesion Kinase Inhibits Growth of Human Colon Carcinoma Xenograft in Nude Mice. JOURNAL OF BIOMEDICAL NANOTECHNOLOGY . 2010
  • 6Canel Marta,Serrels Alan,Miller Derek,Timpson Paul,Serrels Bryan,Frame Margaret C,Brunton Valerie G.Quantitative in vivo imaging of the effects of inhibiting integrin signaling via Src and FAK on cancer cell movement: effects on E-cadherin dynamics. Cancer Research . 2010
  • 7Kiefel Helena,Bondong Sandra,Pfeifer Marco,Schirmer Uwe,Erbe-Hoffmann Natalie,Sch?fer Heiner,Sebens Susanne,Altevogt Peter.EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation. Carcinogenesis . 2012
  • 8Anthony D. Yang,Fan Fan,E. Ramsay Camp,George van Buren,Wenbiao Liu,Ray Somcio,Michael J. Gray,Haiyun Cheng,Paulo M. Hoff,Lee M. Ell.Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines. Clinical Cancer Research . 2006
  • 9Peinado Héctor,Olmeda David,Cano Amparo.Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nature reviews. Cancer . 2007
  • 10Shen L,Qu X,Ma Y,et al.Tumor suppressor NDRG2 tips the balance of oncogenic TGF-beta via EMT inhibition in colorectal cancer. Oncegene . 2014

二级参考文献56

  • 1Tao Li,Mei Ha Leong,Bruce Harms,Gregory Kennedy,Lin Chen.MicroRNA-21 as a potential colon and rectal cancer biomarker[J].World Journal of Gastroenterology,2013,19(34):5615-5621. 被引量:16
  • 2PYNE S, LEE SC, LONG J, et al. Role of sphingosine kinases and lipid phosphate phosphatases in regulating spatial sphingo- sine 1-phosphate signalling in health and disease[J]. Cell Signal, 2009, 21(1): 14-21.
  • 3ALEMANY R, VAN KOPPEN C J, DANNEBERG K, et al. Reg- ulation and functional roles of sphingosine kinases [J]. Naunyn Schmiedebergs Arch Pharmacol, 2007, 374(5-6): 413-428.
  • 4SADDOUGHI SA, SONG P, OGRETMEN B. Roles of bioactive sphingolipids in cancer biology and therapeutics [J]. SubcellBiochem, 2008, 49: 413-440.
  • 5YOUNG N, PEARL DK, VAN BROCKLYN JR. Sphingo- sine-l-phosphate regulates glioblastoma cell invasiveness throughthe urokinase plasminogen activator system and CCNI/Cyr61 [J]. Mol Cancer Res, 2009, 7(1): 23-32.
  • 6TAKABE K, PAUGH SW, MILSTIEN S, et al. "Inside-out" sig- naling of sphingosine-l-phosphate: therapeutic targets[J]. Pharma- col Rev, 2008, 60(2): 181-195.
  • 7CUVILLIER O, ADER I, BOUQUEREL P, et al. Activation of sphingosine kinase-1 in cancer: implications for therapeutic tar- geting[J]. Curr Mol Pharmacol, 2010, 3(2): 53-65.
  • 8SARKAR S, MACEYKA M, HAIT NC, et al. Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells [J]. FEBS Lett, 2005, 579 (24): 5313-5317.
  • 9KAPITONOV D, ALLEGOOD JC, MITCHELL C, et al. Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis,and suppresses growth of human glioblastoma eells and xenografts [J]. Cancer Res, 2009, 69(17): 6915-6923.
  • 10GUILLERMET-GUIBERT J, DAVENNE L, PCHEJETSKI D, et al. Targeting the sphingolipid metabolism to defeat pancreaticcancer cell resistance to the chemotherapeutie gemcitabine drug [J]. Mol Cancer Ther, 2009, 8(4): 809-820.

共引文献38

同被引文献31

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部